Diabetes Technology in Saudi Arabia: Current Status and Future Directions
Mohammed E Al-Sofiani1,2, Abdulhalim M Al-Murashi3, Nada A Al-Agil4
1Division of Endocrinology, Diabetes and Metabolism, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Background:
The increasing incidence and prevalence of diabetes have led to a strain on health care systems, necessitating innovation in diabetes care delivery and substantial resource allocation for disease management and treatment of complications. Recently, Saudi Arabia has made significant strides in digital transformation, implementing cutting-edge technologies across various sectors, including the health sector.
Aims:
To develop a report that examines the current status, identify challenges and opportunities in implementing diabetes technology solutions for diabetes management, and provide a strategic roadmap for enhancing the accessibility to diabetes technology solutions.
Methods:
The Saudi National Diabetes Center (SNDC) convened a group of experts to develop a comprehensive report that serves a dual purpose. First, it provides a narrative review on insulin pumps and CGMs that are approved by the SFDA and discusses their clinical effectiveness based on local studies. Second, it presents a comprehensive report on the current status and future directions of diabetes technology in Saudi Arabia.
Results:
Our experts identified six major barriers to the adoption of diabetes technology solutions in Saudi Arabia and proposed 14 strategic initiatives that can help overcome these barriers and transform the current overwhelmed diabetes care model into a more innovative, effective, efficient, safe, accessible, and cost-effective model of care.
Conclusion:
While Saudi Arabia offers one of the most diverse ranges of diabetes technology solutions globally, major accessibility barriers persist. The SNDC Diabetes Technology Report is the first report developed primarily for policymakers, regulatory bodies, clinicians, academicians, and industry partners to address these accessibility barriers.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
